It should not be presented as an approved UK treatment for insomnia, ageing, telomere shortening, retinal disease, cancer prevention, circadian disruption or another medical condition
US Market Access Strategy Consulting Shapeshifting market Todays patients that initiate GLP-1 treatment particularly the treatments with explicit weight loss indications or strong clinical data for weight loss look less like the typical diabetes patients they used to resemble
From the Incretin concept and the discovery of GLP-1 to Todays Diabetes Therapy
Known as the master antioxidant, glutathione plays a vital role in detoxifying harmful substances, neutralising free radicals, and supporting the immune system
Magnesium is considered a natural calcium channel blocker, meaning it prevents calcium from building up in your arteries
Given the relationship between diabetes and chronic kidney disease, it should come as no surprise that GLP1 receptor agonists can positively impact the clinical trajectory of those with kidney disease